A slide lecture program in 4 modules, with over 180 PPt slides with a focus on approaches to manage CV risk in patients with T2D
 

Approaches to managing CV risk in patients with T2D

A slide lecture program on type 2 diabetes, glycaemic control, weight loss, control of dyslipidaemia & multifactorial approach to reducing CV events in T2DM

 

Evidence for effects of older glucose-lowering agents on CV risk

A slide lecture program on glucose lowering agents on CV risk, like: metformin, sulphonylureas, TZDs, and a rationale for FDA guidance

 

Evaluating CV safety and potential for CV risk reduction with newer T2D agents

A slide lecture program on glucose lowering agents on CV risk, like: DPP4 inhibitors, GLP1 agonists, SGLT2 inhibitors

 

Cardiovascular disease and Type 2 Diabetes

A slide lecture program on type 2 diabetes, the pathophysiology, T2DM as CV risk factor & additional risk factors